Goldenwell Biotech, Inc. (GWLL) stock
GWLLOTCFood and Kindred ProductsFiscal year ends December 31
$0.65+0.05 (+8.33%)
Close on Oct 19, 2026Market cap $64.35MP/E –Yield –
Goldenwell Biotech total assets
Total assets on the balance sheet at the end of each period.
Goldenwell Biotech's total assets was $28.98K at Jun 30, 2026. For fiscal 2025 it was $36.12K, down 83.9% from the year before. The highest annual figure on record is $460.98K in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $36.12K | -83.9% |
| FY2024 | Dec 31, 2024 | $224.19K | -1.7% |
| FY2023 | Dec 31, 2023 | $228.09K | -8.2% |
| FY2022 | Dec 31, 2022 | $248.40K | -46.1% |
| FY2021 | Dec 31, 2021 | $460.98K | +85.5% |
| FY2020 | Dec 31, 2020 | $248.57K | +0.8% |
| FY2019 | Dec 31, 2019 | $246.59K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $28.98K | -89.2% |
| Q1 FY2026 | Mar 31, 2026 | $18.75K | -90.2% |
| Q4 FY2025 | Dec 31, 2025 | $36.12K | -83.9% |
| Q3 FY2025 | Sep 30, 2025 | $233.76K | +30.3% |
| Q2 FY2025 | Jun 30, 2025 | $267.32K | +33.4% |
| Q1 FY2025 | Mar 31, 2025 | $191.92K | -3.5% |
| Q4 FY2024 | Dec 31, 2024 | $224.19K | -1.7% |
| Q3 FY2024 | Sep 30, 2024 | $179.43K | -4.0% |
| Q2 FY2024 | Jun 30, 2024 | $200.40K | +4.2% |
| Q1 FY2024 | Mar 31, 2024 | $198.97K | -9.3% |
| Q4 FY2023 | Dec 31, 2023 | $228.09K | -8.2% |
| Q3 FY2023 | Sep 30, 2023 | $186.93K | -29.7% |
| Q2 FY2023 | Jun 30, 2023 | $192.34K | -29.9% |
| Q1 FY2023 | Mar 31, 2023 | $219.42K | -28.9% |
| Q4 FY2022 | Dec 31, 2022 | $248.40K | -46.1% |
| Q3 FY2022 | Sep 30, 2022 | $266.08K | -45.2% |
| Q2 FY2022 | Jun 30, 2022 | $274.40K | -46.1% |
| Q1 FY2022 | Mar 31, 2022 | $308.69K | -29.1% |
| Q4 FY2021 | Dec 31, 2021 | $460.98K | +85.5% |
| Q3 FY2021 | Sep 30, 2021 | $485.85K | +93.9% |
| Q2 FY2021 | Jun 30, 2021 | $509.18K | +106.5% |
| Q1 FY2021 | Mar 31, 2021 | $435.18K | – |
| Q4 FY2020 | Dec 31, 2020 | $248.57K | – |
| Q3 FY2020 | Sep 30, 2020 | $250.54K | – |
| Q4 FY2019 | Dec 31, 2019 | $246.59K | – |
See a number that looks wrong?